New Key Statistics Module, Z-Score and F-Score
NAS:ADPT Key Ratios
| Market Cap $ M | 382.32 |
| Enterprise Value $ M | 131.06 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.24 |
| Price/Sales | 2.28 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 170.00 |
| EPS (TTM) $ | -1.56 |
| Beneish M-Score | -2.83 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -20.60 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.62 |
| EV-to-EBITDA | -0.69 |
| PEG | -- |
| Shares Outstanding M | 145.09 |
| Net Margin (%) | -132.29 |
| Operating Margin % | -118.40 |
| Pre-tax Margin (%) | -132.32 |
| Quick Ratio | 4.50 |
| Current Ratio | 4.66 |
| ROA % (ttm) | -29.71 |
| ROE % (ttm) | -57.63 |
| ROIC % (ttm) | -56.04 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.00 |
ADPT Number of Guru Trades
ADPT Volume of Guru Trades
Gurus Latest Trades with NAS:ADPT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ADPT is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Adaptive Biotechnologies Corp Insider Transactions
No Available Data
News about NAS:ADPT
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers